Get the Stockscreener App
3.205
2.58%
-0.085
Galecto Inc stock is traded at $3.205, with a volume of 4,417.
It is down -2.58% in the last 24 hours and down -6.01% over the past month.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
See More
Previous Close:
$3.29
Open:
$3.26
24h Volume:
4,417
Relative Volume:
0.11
Market Cap:
$4.24M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-2.2103
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
-14.53%
1M Performance:
-6.01%
6M Performance:
-35.38%
1Y Performance:
-76.73%
1-Day Range:
$3.1401
$3.26
1-Week Range:
$3.10
$3.90
52-Week Range:
$2.01
$15.13
Galecto Inc Stock (GLTO) Company Profile
Name
Galecto Inc
Sector
Industry
Phone
45-70-70-52-10
Address
75 STATE STREET, BOSTON
Compare GLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLTO
Galecto Inc
|
3.205 | 4.35M | 0 | -38.35M | -36.91M | -1.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Nov-23-20 | Initiated | BofA Securities | Buy |
| Nov-23-20 | Initiated | Credit Suisse | Outperform |
| Nov-23-20 | Initiated | SVB Leerink | Outperform |
Galecto Inc Stock (GLTO) Latest News
What MACD signals say about Galecto Inc.Free Pattern Alert With ROI Driven Strategy - Newser
Can swing trading help recover from Galecto Inc. lossesPortfolio Safety Metrics and Return Analysis - Newser
What makes Galecto Inc. stock price move sharplyFree Swing Trading Plan With Smart Signals - Newser
Technical analysis overview for Galecto Inc. stockFree Smart Money Tracking Signal Generator - Newser
Is Galecto Inc. a growth stock or a value stockStock Market Picks With High Returns - jammulinksnews.com
How to track smart money flows in Galecto Inc.AI Pattern Recognition and Trade Prediction - Newser
Is Galecto Inc. stock overvalued or undervaluedMarket Forecast Planner With Proven Results - jammulinksnews.com
Why is Galecto Inc. stock attracting strong analyst attentionReal Time Guidance From AI Tools - jammulinksnews.com
Can trapped investors hope for a rebound in Galecto Inc.Short-Term Sector Movement Forecast Generator - Newser
Published on: 2025-07-31 01:11:31 - Newser
Published on: 2025-07-30 11:02:55 - metal.it
Sectors Driving Future Growth for Galecto Inc. StockSmart Trade Mapping with Entry Details - Newser
Leading vs lagging indicators on Galecto Inc. performanceDaily Equity Signal Strength Summary Report - Newser
How Efficient Is Galecto Inc. at Controlling Operating CostsFree Triple Digit Growth Focused Trade Plan - Newser
Does Galecto Inc. stock perform well during market downturnsFree Stock Recommendation With Proven Results - jammulinksnews.com
How many analysts rate Galecto Inc. as a “Buy”Navigate market shifts with confidence - jammulinksnews.com
Technical Models Detect Momentum Build in Galecto Inc.Step-by-Step Stock Investment Guide Gains Popularity - metal.it
When is Galecto Inc. stock expected to show significant growthSwing Trade Insights Backed By Experts - jammulinksnews.com
What is the risk reward ratio of investing in Galecto Inc. stockCapitalize on stocks with high profit margins - jammulinksnews.com
Should you wait for a breakout in WideOpenWest Inc.Free Growth Based Investment Plan Guidance - Newser
What are analysts’ price targets for Galecto Inc. in the next 12 monthsBuild wealth steadily with proven investment techniques - jammulinksnews.com
How does Galecto Inc. generate profit in a changing economyAchieve breakthrough investment performance - jammulinksnews.com
What are the latest earnings results for Galecto Inc.Achieve rapid growth with smart investments - jammulinksnews.com
What institutional investors are buying Galecto Inc. stockFree Consultation - jammulinksnews.com
How does Galecto Inc. compare to its industry peersFree Predictions - jammulinksnews.com
Published on: 2025-07-27 22:11:57 - jammulinksnews.com
What makes CleanSpark Inc. Equity Warrant stock price move sharplyFree Professional Trading Signals - Newser
How Interest Rate Changes Impact Galecto Inc. Stock PerformanceFree Elite Traders Group - Newser
What makes SpringWorks Therapeutics Inc. stock price move sharplyDaily Gain Forecast - Newser
How BRP Inc. stock performs during market volatilityFree Access to Community - Newser
How NBT Bancorp Inc. stock performs during market volatilityMulti Bagger Alerts - Newser
Quality RO Industries Limited (543460)’s Trend in 2025Rapid profit acceleration - PrintWeekIndia
Will Galecto Inc. stock benefit from AI tech trendsUnmatched market performance - jammulinksnews.com
Is Galecto Inc. a good long term investmentBreakthrough investment results - PrintWeekIndia
What analysts say about Galecto Inc. stockFree Real-Time Stock Data - PrintWeekIndia
Galecto Inc Stock (GLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Galecto Inc Stock (GLTO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Winslow Garrett | General Counsel |
Jul 03 '25 |
Sale |
3.39 |
260 |
881 |
1,429 |
| Firmani Lori | Interim CFO |
Jul 03 '25 |
Sale |
3.39 |
147 |
498 |
692 |
| Winslow Garrett | General Counsel |
Jan 03 '25 |
Sale |
5.60 |
471 |
2,638 |
1,009 |
| Firmani Lori | Interim CFO |
Jan 03 '25 |
Sale |
5.63 |
261 |
1,469 |
465 |
| Schambye Hans T. | Chief Executive Officer |
Jan 03 '25 |
Sale |
5.60 |
1,341 |
7,510 |
3,397 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):